Payoneer Sets September 14 Vote on $2.75B Nuvei Buyout; HSR Clearance Obtained
PAYO sits 74% above its 52-week low of $4.08.
Summary
Payoneer's definitive proxy sets September 14, 2026 as the stockholder vote date on Nuvei's $2.75 billion all-cash acquisition. Early HSR clearance was granted, but a stockholder demand letter alleges proxy omissions.
Key Events · M&A and Partnerships · PAYO
-
Stockholder Vote Set for September 14
A special meeting will be held on September 14, 2026, for stockholders to vote on the $2.75 billion all-cash acquisition by Nuvei at $7.40 per share. The record date is August 6, 2026.
-
HSR Clearance Obtained
Early termination of the Hart-Scott-Rodino waiting period was granted on July 28, 2026, satisfying one of the key regulatory conditions to closing.
-
Stockholder Litigation Risk
A purported stockholder sent a demand letter alleging that the preliminary proxy omitted material information about the merger. Payoneer believes the claims are without merit but cannot predict the outcome.
-
Executive Golden Parachute Compensation Disclosed
The proxy quantifies merger-related compensation for named executive officers: CEO John Caplan could receive ~$35.2M, CFO Bea Ordonez ~$17.4M, and CLO Tsafi Goldman ~$7.4M, primarily from accelerated equity vesting.
Analysis · PAYO · Trade & Services
The definitive proxy from Payoneer locks in the stockholder vote on the $2.75 billion all-cash acquisition by Nuvei at $7.40 per share. A key regulatory hurdle was cleared when early HSR termination was granted on July 28. The filing also flags a risk: a stockholder demand letter alleges inadequate disclosures, which could delay the vote. With the record date set and the meeting scheduled, the merger remains on track to close in mid-2027, pending other approvals. The $7.40 price represents a 44% premium to the undisturbed price, and the board unanimously recommends approval.
At the time of this filing, PAYO was trading at $7.09 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $4.08 to $7.18. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.